Biotech Values

[DewDiligence]

4Q23 worldwide Botox sales=$1.484B, +8% QoQ* +8% YoY:

https://news.abbvie.com/2024-02-02-AbbVie-Reports-Full-Year-and-Fourth-Quarter-2023-Financial-Results

• US therapeutic: $649M (+4% QoQ, +6% YoY)
• US cosmetic: $453M (+17% QoQ*, +7% YoY)
--
US total: $1.102B (59% therapeutic; 41% cosmetic) was 74% of worldwide total


• Ex-US therapeutic: $127M (+4% QoQ, +12% YoY
• Ex-US cosmetic: $265M (+13% QoQ, +21% YoY)
--
Ex-US total: $382M (33% therapeutic; 67% cosmetic) was 26% of worldwide total.


*In the US market, botulinum-toxin sales for cosmetic indications are seasonally stronger during the second and fourth calendar quarters than the first and third calendar quarters.